How Softbank went from a tech investor to a big hedge fund
Softbank, the Japanese technology investor, appears to be gambling rather than investing these days. Shareholders are rattled. Matthew Partridge reports.
The Japanese conglomerate SoftBank, run by Masayoshi Son, is among the world’s “biggest and most controversial” technology firms, say Matthew Field and Hasan Chowdhury in The Daily Telegraph. While it is known to focus on “young, privately-held companies”, SoftBank is now revealed to have made large bets on publicly-traded tech companies too.
It purchased $4bn of call options on tech firms. These instruments, which allow it to buy a stock at a certain price, turned the firm into a “whale”: an investor so large they automatically drive the market up if they make a purchase.
SoftBank may claim to have made $4bn in paper profits from its unusual strategy, but it is unclear whether any money will remain once the dust clears, says Jennifer Hughes on Breakingviews. Already, a “sharp downturn” in US tech stocks at the end of last week has wiped more than 10% off the Nasdaq Composite index (see page 4).
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
At the same time, SoftBank’s own shares tumbled by 5% once its activities in the options market were revealed, cutting its market cap by $7bn. In any case, even if the deals make money, this is “beside the point”: SoftBank investors can bet on publicly-traded US tech stocks “without Son’s assistance”.
A poor record
It’s hard to disagree with investors who feel that not only is Son’s gambling luck unlikely to hold, but his company also shouldn’t be behaving like a “drunken hedge fund”, says Nils Pratley in The Guardian. After all, Son’s record on timing market movements over short periods “does not impress” given that he lost $70bn during the dotcom crash in the 2000s.
The entire episode suggests that Son now prefers the “fun” of “leveraged bets and short-term risk-taking” to the more complicated task of finding long-term opportunities. These latest revelations not only raise questions about Son’s judgement, which had been called into question before, but also underlines concerns about how “poorly governed” and “financially opaque” the Japanese tech group is, says Lex in the Financial Times. Even before the latest debacle, SoftBank’s reports were just a “mish-mash” of valuation swings – many of which have proven to be wide of the mark – and extracts from the reports of companies Softbank invested in. Investors need to realise that, despite SoftBank’s public listing and retail investor base, it is little more than a “big hedge fund”.
All these problems have resulted in SoftBank having a “deep discount” to its stated net assets, says Jacky Wong in The Wall Street Journal. Ironically, this discount had started to narrow from its March peak thanks to the prudent decision to sell or monetise $42bn-worth of assets to buy back shares and redeem debt. All the progress looks set to be reversed as the “lack of transparency” on this new investment gambit widens this discount further.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Working from home: is it working?
While Labour plans to make working from home the legal default, some employers are calling workers back into the office. What does the future hold?
By Simon Wilson Published
-
International Investment Summit: will the government's growth plans boost investor portfolios?
News The government is looking to attract investment into UK projects. We explain what this could mean for your money
By Marc Shoffman Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
LSL Property Services: a profit-machine in the property sector
LSL covers every area of the residential real estate market and should thrive after its shake-up
By Rupert Hargreaves Published
-
Top global fintech companies to invest in
One British fintech hogs the headlines, but there are two top performers in the US. We explain where you should put your money
By David C. Stevenson Published
-
Global car shares slide amid lower demand in China – what happens now?
Has the car sector run into trouble? Britain’s Aston Martin and Germany’s Volkswagen are among the key automobile brands that have issued profit warnings.
By Alex Rankine Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
How to invest in the quiet market months
Here's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
By Cris Sholto Heaton Published
-
Spire Healthcare: invest in the booming demand for private healthcare
Spire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
By Rupert Hargreaves Published
-
Are insurance companies a good investment?
Costs may be soaring but the insurance sector is currently going through one of its most profitable periods. The market has been slow to realise the opportunity here
By Rupert Hargreaves Published